Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia

Summary

The purpose of this study is to evaluate the long-term efficacy and safety profile of tosedostat in elderly patients suffering from refractory or relapsed Acute Myeloid Leukemia.

Timeline

Start

2010-06

Primary completion

2013-06

Completion

2013-06

Drugs

Indications